메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

European Union and Vietnam: A joint path to poultry farming based on immunity and prevention

HANOI, Vietnam, Nov. 18, 2025 -- To mark the World Antimicrobial Resistance (AMR) Awareness Week, which begins today (18–24 November), the EU co-financed the 'European Poultry – From Our Farms to Your Tables' information and promotional campaign to highlight Vietnam's progress in the rational use of antibiotics in poultry production and the compatibility of European standards with local market expectations. Vietnam accelerates changeIn 2018, the Vietnamese government prohibited the use of antibiotic growth promoters in livestock feed. It also adopted a roadmap to phase out the
- 황정호 기자
- 2025-11-18 07:00
유럽 가금류 업계, 동물에 대한 예방적이고 책임 있는 접근 강조

서울, 대한민국, 2025년 11월 18일 -- 오늘(11월 18~24일) 시작되는 세계 항생제 내성(AMR) 인식 주간(World Antimicrobial Resistance Awareness Week)을 맞아, 유럽연합(EU)은 항생제 내성(AMR) 감소를 위한 유럽 가금류 생산업체의 노력을 조명하기 위해 EU 공동 자금으로 지원되는 '유럽 가금류 – 우리의 농장에서 당신의 식탁까지(European Poultry – From Our Farms to Your Tables)' 정보 및 홍보 캠페인을 진행한다. 유럽연합은 질병으로 인한 치료가 필요한 경우를 제외하고, 동물 생산 과정에서 항생제 사용을 금지하고 있다. 치료가 필요한 경우에도 엄격한 수의학적 감독 아래에서만 이루어지며, 잔류물이 법적 기준 내에 있도록 휴약기간을 철저히 준수한다. EU는 예방과 동물복지를 최우선으로 두고 있으며, '농장에서 식탁까지(Farm to Fork)' 전략에 따라 높은 식품 안전과 전 과정 추적성 수준을 유지하면서 항생제 사용을 더욱 줄이는 것을 목표로 한다. 실제 현장에서 어떻게 운영되는가?유럽의 가금류 생산업체들은 현장에서 엄격한
- 황정호 기자
- 2025-11-18 07:00
Reaching Young People with Real-Time, Human-Centred Support: Cancer Council to Launch AI for Youth Vaping Cessation

SYDNEY, Nov. 18, 2025 -- Miroma Project Factory (MPF) is proud to announce the successful completion of the Technical Feasibility Assessment (TFA) and Proof of Concept (POC) for an AI-powered vaping cessation support tool designed specifically for young Australians aged 14 to 25, in collaboration with Cancer Council NSW. With vaping rates rising and traditional cessation tools failing to connect with younger audiences, this early-stage work represents a crucial step in ensuring any eventual AI solution is both effective and safe. By focusing first on technical feasibility, the
- 김장윤(JASON KIM) 기자
- 2025-11-18 05:07
Ulanzi Unveils Move LightGo: High-Precision Remote Lighting Control, Scene Memory & Multi-Unit Sync for Enhanced Shooting Efficiency

HONG KONG, Nov. 18, 2025 -- Ulanzi, a leading innovator in photography accessories, announced the release of its latest innovation - Move LightGo. It is a groundbreaking remote lighting control system to boost efficiency and productivity for photographers and filmmakers. The Move LightGo combines 14-bit high-precision hardware control and a high-precision control sensor, offering drastically improved lighting setup efficiency than traditional manual adjustments, with 95% Bowens-mount compatibility for mainstream professional lighting equipment. Product Highlights:&nb
- 김장윤(JASON KIM) 기자
- 2025-11-18 00:30
TEACHING AWARDS TRUSTが新たな「エデュケーション・インサイツ（EDUCATION INSIGHTS）」イベント・シリーズを開始

Nord Anglia Educationとの提携による新しい取り組みでは、教育者と世界的な思想的リーダーを集め、教育の未来を形作るテーマを探求します David Olusoga氏（OBE）、Floella Benjamin氏（DBE）、そして元「Educating Yorkshire」の学生であるMusharaf Asghar氏など、影響力のある講演者がラインナップに加わっていますロンドン, 2025年11月17日 -- Nord Anglia Educationの支援を受けるTeaching Awards Trustは、教育に焦点を当てた地域イベントのまったく新しいシリーズ、エデュケーション・インサイツ（Education Insights）を立ち上げます。2026年1月から始まるこのイベントでは、教師、学校のリーダー、地域の意思決定者と、スポーツ、テクノロジー、ビジネス、政治界の第一人者を結び付け、若者の生活を形作る決定的な問題と、若者の潜在能力を最大限に引き出す方法を探ります。このシリーズは1月27日にマンチェスターで「回復力に焦点を当てる（A Focus on Resilience）」というテーマで開幕し、「Educating Yorkshire」の元学生であるMusharaf Asghar氏が基調講演を行います。このプログラムは
- 황정호 기자
- 2025-11-18 00:25
Canary Speech Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Technology Innovation Leadership

[ 메디채널 김갑성 기자 ] Recognized for transforming Intelligent Vocal Biomarker Diagnostics through innovative AI-powered, smartphone-based diagnostic solutions SAN ANTONIO, Nov. 17, 2025 -- Frost & Sullivan is pleased to announce that Canary Speech, a global leader in AI-powered vocal biomarker technology, has received the 2025 North America Technology Innovation Leadership recognition in the intelligent vocal biomarker diagnostics industry for its outstanding achievements in technology innovation. This recognition highlights Canary Speech's consistent leadership in driving measurable o
- 김갑성 기자
- 2025-11-17 23:00
シュピールヴァーレンメッセ開催75周年 - 祝って、発見して、つながって

見本市会場と「トイシティ」ニュルンベルクで、多彩なイベントを展開特別に表彰：第1回からのご出展に感謝を込めて15社を表彰ニュルンベルク、ドイツ, 2025年11月17日 -- 2026年に開催75周年を祝うシュピールヴァーレンメッセ。開幕75日前の11月13日に、オンラインマガジン『スピリット・オブ・プレイ（Spirit of Play）』にてカウントダウンがスタートしました。2026年1月27日から31日の会期中、ニュルンベルクの見本市会場は、世界中の玩具業界にとって唯一無二の体験ができる場所へと変わります。さまざまな企画が目白押し、インタラクティブなコンテンツ、そして人と人が触れ合う今回の記念開催は、業界にとって欠かせない、まさに「集うべき場所」となります。一度きりの特別な開催「この特別な会に、これまで支えてくださった皆さまへの感謝を込めて、ご自身のシュピールヴァーレンメッセを特別な雰囲気の中で体験していただけるようさまざまな企画を考えました」そう語るのは、シュピールヴァーレンメッセ社広報担当取締役のクリスティアン・ウルリヒ。すでにカウントダウンは始まっています。オンラインマガジン『スピリット・オブ・プレイ（Spirit of Play）』では、1950年に「ドイツ玩具専門見本市」
- 김장윤(JASON KIM) 기자
- 2025-11-17 22:34
Ajinomoto Bio-Pharma Services Wins "Best ADC Preclinical Publication 2024" Award for AJICAP® Technology at 2025 World ADC Awards

Recognition underscores Ajinomoto Bio-Pharma Services' innovation and scientific excellence in advancing next-generation antibody-drug conjugate technologies TOKYO, Nov. 17, 2025 -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, today announced it has been named the winner of the "Best ADC Preclinical Publication 2024" at the 12th Annual World ADC Awards, recognizing the company's innovative research publication on the AJICAP® linker technology. The honored
- 김갑성 기자
- 2025-11-17 22:26
Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs

BOSTON, Nov. 17, 2025 -- Bambusa Therapeutics, Inc. ("Bambusa"), a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology and inflammation (I&I), today announced the completion of its oversubscribed Series A-2 financing, closed at a substantial valuation step-up over the prior round. This Series A-2 financing reflects strong participation from Bambusa's existing investors, including Athos KG, RA Capital Management, INCE Capital, Redmile Group, BVF Partners L.P., Salvia GmbH, Janus Henderson Investors, Inv
- 김갑성 기자
- 2025-11-17 22:15
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US

SHANGHAI and JERSEY CITY, N.J., Nov. 17, 2025 -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® (pertuzumab-dpzb) 420 mg/14 mL injection for intravenous use, an interchangeable biosimilar to PERJETA (pertuzumab), for all indications of the reference product.[1] POHERDY is the first and only approved pertuzumab biosimilar in the US, representing an important milestone in expanding access to quality and potentially more affordable biologic thera
- 김갑성 기자
- 2025-11-17 22:06

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-11-19_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 19일 18시 40분